- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
TheStreet's Adam Feuerstein answers reader questions about biotech stocks.
This big pharmaceutical player's recent woes could be good news for its rivals, but it also poses risks for investors.
Eli Lilly built up much false hope by being far too bullish on its now-failed Alzheimer treatment, Cramer said.